Janikiewicz P, Wasilewska B, Mazur U, Franke-Radowiecka A, Majewski M, Bossowska A
Int J Mol Sci. 2021; 22(24).
PMID: 34948196
PMC: 8708101.
DOI: 10.3390/ijms222413399.
Bossowska A, Lepiarczyk E, Janikiewicz P, Wasilewska B, Mazur U, Markiewicz W
Int J Mol Sci. 2021; 22(9).
PMID: 34063103
PMC: 8124201.
DOI: 10.3390/ijms22094896.
ROKSETH R, STORSTEIN O, Voll A, Abrahamsen A, Ofstad J
Br Heart J. 1962; 24:195-200.
PMID: 14493458
PMC: 1017868.
DOI: 10.1136/hrt.24.2.195.
PALMER K, McDONALD G
Postgrad Med J. 1962; 38:338-40.
PMID: 14483414
PMC: 2481786.
DOI: 10.1136/pgmj.38.440.338.
KADZIELAWA K
Br J Pharmacol Chemother. 1962; 19:74-84.
PMID: 14453004
PMC: 1482245.
DOI: 10.1111/j.1476-5381.1962.tb01428.x.
Guanethidine administration in 28 hypertensive patients.
Pigeon G, Davignon J, Biron P, Trudel J, DUFAULT C, Genest J
Can Med Assoc J. 1960; 83:690-5.
PMID: 14432939
PMC: 1938705.
NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.
MIZGALA H
Can Med Assoc J. 1965; 92:918-22.
PMID: 14289140
PMC: 1928040.
GUANETHIDINE AND PUPILLARY REACTION.
DORIAN W, SCHIRMER K
Can Med Assoc J. 1964; 90:932-3.
PMID: 14139993
PMC: 1922601.
Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.
Hertting G, Axelrod J, PATRICK R
Br J Pharmacol Chemother. 1962; 18:161-6.
PMID: 14036196
PMC: 1482176.
DOI: 10.1111/j.1476-5381.1962.tb01159.x.
Evidence for a competitive antagonism of guanethidine by dexamphetamine.
DAY M, Rand M
Br J Pharmacol Chemother. 1963; 20:17-28.
PMID: 14025626
PMC: 1703752.
DOI: 10.1111/j.1476-5381.1963.tb01293.x.
Effect of guanethidine, hemicholinium and mebutamate on the hypertensive response to eserine and catechol amines.
VARAGIC V, VOJVODIC N
Br J Pharmacol Chemother. 1962; 19:451-7.
PMID: 13996274
PMC: 1482221.
DOI: 10.1111/j.1476-5381.1962.tb01449.x.
Mechanism of the positive inotropic responses to bretylium and guanethidine.
Bhagat B, SHIDEMAN F
Br J Pharmacol Chemother. 1963; 20:56-62.
PMID: 13967966
PMC: 1703759.
DOI: 10.1111/j.1476-5381.1963.tb01296.x.
Mechanism of the initial adrenergic effects of bretylium and guanethidine.
Gokhale S, Gulati O, Kelkar V
Br J Pharmacol Chemother. 1963; 20:362-77.
PMID: 13948620
PMC: 1703630.
DOI: 10.1111/j.1476-5381.1963.tb01475.x.
Tissue amine levels and sympathetic blockade after guanethidine and bretylium.
CASS R, SPRIGGS T
Br J Pharmacol Chemother. 1961; 17:442-50.
PMID: 13877106
PMC: 1482083.
DOI: 10.1111/j.1476-5381.1961.tb01131.x.
Evaluation of guanethidine in the comprehensive treatment of hypertension. A study of 25 cases.
Pomerantz H, BARSKEY S, BALLON J, Neiman G, LAPIN A
Can Med Assoc J. 1961; 85:191-4.
PMID: 13736944
PMC: 1848179.
Supersensitivity of salivary glands following treatment with bretylium or guanethidine.
EMMELIN N, Engstrom J
Br J Pharmacol Chemother. 1961; 16:315-9.
PMID: 13726638
PMC: 1482020.
DOI: 10.1111/j.1476-5381.1961.tb01090.x.
Guanethidine in treatment of hypertension.
BAUER G, CROLL F, GOLDRICK R, JEREMY D, Raftos J, WHYTE H
Br Med J. 1961; 2(5249):410-5.
PMID: 13687896
PMC: 1969277.
DOI: 10.1136/bmj.2.5249.410.
The discovery of bretylium and bethanidine.
GREEN A
Br J Clin Pharmacol. 1982; 13(1):25-34.
PMID: 7066153
PMC: 1401770.
DOI: 10.1111/j.1365-2125.1982.tb01333.x.
Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).
Vejlsgaard V, Christensen M, Clausen E
Br Med J. 1967; 2(5552):598-600.
PMID: 6025595
PMC: 1842098.
DOI: 10.1136/bmj.2.5552.598.
Peripheral noradrenaline and adrenergic transmission in the rat.
SPRIGGS T
Br J Pharmacol Chemother. 1966; 26(1):271-81.
PMID: 5919511
PMC: 1510769.
DOI: 10.1111/j.1476-5381.1966.tb01830.x.
